EHC remains well-poised for growth on the back of improved revenues, an extensive rehabilitation hospital network and sufficient cash-generating abilities.
In the latest trading session, DaVita HealthCare (DVA) closed at $159.07, marking a -0.03% move from the previous day.
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.